US hospital says “no” to spiralling price of oncology drugs

In an op-ed in the New York Times on 14 September 2012, Memorial Sloan-Kettering Cancer Center published the rationale for their decision not to give Sanofi and Regeneron’s new drug, Zaltrap, to their patients with colorectal cancer. The authors cite … Continue reading

New EMA guidance available for Parkinsons and Diabetes, CF endpoint workshop dates announced

In the past few weeks the European Medicines Agency has released updated guidance in a number of disease areas, including Parkinsons and diabetes, and they have published the dates of a workshop to discuss endpoints in development of new drugs … Continue reading